课题基金 / 基金详情

Development of analytical method of molecular function in protein kinases by using newly synthesized protein kinase inhibitor - affinity chromatography

Development of analytical method of molecular function in protein kinases by using newly synthesized protein kinase inhibitor - affinity chromatography
利用新合成的蛋白激酶抑制剂-亲和层析法开发蛋白激酶分子功能分析方法
批准号:
62880018
负责人:
HIDAKA Hiroyoshi
金额:
$4.03万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1988

项目摘要

项目成果

HIDAKA Hiroyoshi的其他基金

相关文献

中文摘要
翻译
用蛋白激酶抑制剂亲和层析法成功地从兔脑中分离纯化了蛋白激酶C,并从鸡肌球蛋白轻链和人血小板中分离纯化了肌球蛋白轻链蛋白。用纯化的C蛋白进行氨基酸序列测定。对兔三种不同类型的蛋白激酶C(α、β和GAM)的互补DNA克隆进行了鉴定和测序,然后用羟基磷灰石柱层析将其分为三种亚型。我们获得了三种类型的蛋白激酶C单抗,它们可以选择性地与羟基磷灰石柱层析分离的同工酶相互作用,即I、II和III型蛋白激酶。为阐明蛋白激酶C在血管平滑肌收缩中的作用,本实验观察了外源性蛋白激酶C对兔肠系膜动脉平滑肌标本的作用。已阐明肌球蛋白轻链蛋白激酶C的磷酸化在血管平滑肌收缩中起抑制作用。MLCK被A激酶(2摩尔磷酸盐/MLCK摩尔)磷酸化。甲状旁腺素被认为是A蛋白磷酸化的一个部位是钙调蛋白结合部位。利用蛋白激酶抑制剂和亲和纯化的蛋白激酶阐明了血管平滑肌收缩机制中各蛋白激酶之间的相互关系。这些证据表明,蛋白激酶抑制剂-亲和层析可用于研究纯化的蛋白激酶的生理功能,并研究各种蛋白激酶之间的相互关系。
英文摘要
We succeed the purification of protein kinase C from rabbit brain and myosin light chain kinase (MLCK) from chicken gizzard and human platelet by using protein kinase inhibitor-affinity chromatography. The purified C kinase was used to determine amino acid sequence. Rabbit complementary DNA clones cording for three disinct types of protein kinase C, named alpha,beta and gam, have been identified and sequenced.Then, homogenous C-kinase were classified into three subtypes, using hydroxylapatite column chromatography. We obtained three types of protein kinase C monoclonal antibodies which selectively interact with hydroxyapatite column chromatographically resolved isozymes, type i, ii and iii of protein kinase. To clarify the role of protein kinase C in vascular smooth muscle contraction, the effects of exogenous protein kinase C was investigated on skinned smooth muscle preparations of the rabbit mesenteric artery. It was clarified that protein kinase C phosphorylation of myosin light chain play inhibit role in contraction of vascular smooth muscle. MLCK is phosphorylated by A kinase (2 mol of phosphate/mol of MLCK). It was recognized by using thyroxine that one site of phosphorylation by A kinase is calmodulin binding site. We clarified interrelationship among each protein kinase in vascular smooth muscle contraction mechanism using protein kinase inhibitor and affinity purified protein kinase. These evidence suggested that protein kinase inhibitor-affinity chromatography can be used to investigate the physiological function of purified protein kinase and to study interrelation among each protein kinase.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Mamiya et.al.: The Journal of Biologic al Chemistry. (1989)
S.Mamiya 等人:《生物化学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Hagiwara;et al.: Biochemical and biophysical research communications. 152. 270-276 (1988)
M.Hagiwara;等人:生物化学和生物物理研究通讯。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
27
    ELUCIDATION OF THE INTRACELLULAR CALCIUM SIGNAL TRANSDUCTION WITH THE MOLECULAR PHARMACOLOGICAL APPROARCH
    • 批准号:
      06404019
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $22.21万
    • 财政年份:
      1994
    • 负责人:
      HIDAKA Hiroyoshi
    • 依托单位:
    Molecular basis and generation of new compounds for probing phosphorylation-mediated signaling pathways
    • 批准号:
      06507001
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $19.14万
    • 财政年份:
      1994
    • 负责人:
      HIDAKA Hiroyoshi
    • 依托单位:
    Nuclear magnetic resonance studies of calcyclin and annexin XI.
    • 批准号:
      06044105
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $7.04万
    • 财政年份:
      1994
    • 负责人:
      HIDAKA Hiroyoshi
    • 依托单位:
    Establishment of the pharmacological sciences to elucidate the signal transduction system.
    • 批准号:
      04304030
    • 项目类别:
      Grant-in-Aid for Co-operative Research (A)
    • 资助金额:
      $9.6万
    • 财政年份:
      1992
    • 负责人:
      HIDAKA Hiroyoshi
    • 依托单位: